节点文献

含3,4-二氢-2(1H)-喹啉酮结构查尔酮衍生物的合成及蛋白酪氨酸磷酸酯酶1B抑制活性研究

Synthesis and Protein Tyrosine Phosphatase 1B Inhibitory Activity of Novel Chalcone Derivatives Containing 3,4-Dihydroquinolin-2(1H)-one Moiety

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 孙良鹏姜哲高立信李英哲孙立云李佳朴虎日

【Author】 Sun,Liangpenga Jiang,Zheb Gao,Lixinc Li,Yingzhea Sun,Liyuna Li,Jia,c Piao,Huri,a(aKey Laboratory of Natural Resources of Changbai Mountain & Functional Molecules,Ministry of Education,College of Pharmacy,Yanbian University,Yanji 133002)(bYanbian University Hospital,Yanji 133002)(cNational Center for Drug Screening,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203)

【机构】 长白山生物资源与功能分子教育部重点实验室延边大学药学院延边大学附属医院国家新药筛选中心中国科学院上海药物研究所

【摘要】 蛋白酪氨酸磷酸酶1B(PTP1B)作为胰岛素和瘦素信号转导通路的负调节因子,已成为治疗糖尿病和肥胖症的潜在靶标.为了寻找非磷酸酯类PTP1B抑制剂,设计、合成了一系列含3,4-二氢-2(1H)-喹啉酮结构的新型查尔酮衍生物,并对化合物进行了PTP1B抑制活性测定.结果显示,所有化合物对PTP1B均显示出较强的抑制活性,其中化合物(E)-6-{4-[3-(4-氯苯基)-3-氧代-1-丙烯基]苄氧基}-3,4-二氢-2(1H)-喹啉酮(4e)和(E)-6-{4-[3-(3-溴苯基)-3-氧代-1-丙烯基]苄氧基}-3,4-二氢-2(1H)-喹啉酮(4i)活性最佳,IC50分别为(4.64±0.38)和(4.36±0.41)μmol/L.

【Abstract】 Protein tyrosine phosphatase 1B(PTP1B) has recently been identified as new drug target for type II diabetes and obesity due to it is a negative regulator of the insulin and leptin-signaling pathway.In order to find new nonphosphonate-based pTyr mimetics,a series of novel chalcone derivatives bearing the 3,4-dihydroquinolin-2(1H)-one moieties(4a~4n) were designed,synthesized,and evaluated for their PTP1B inhibitory activity.The results demonstrated that all compounds presented potent inhibitory activities against PTP1B,among which compounds 4e and 4i exhibited most potent with IC50value of(4.64±0.38) and(4.36±0.41) μmol/L,respectively.

【基金】 国家自然科学基金(Nos.20962021,81125023)资助项目~~
  • 【文献出处】 有机化学 ,Chinese Journal of Organic Chemistry , 编辑部邮箱 ,2012年11期
  • 【分类号】TQ460.1
  • 【被引频次】17
  • 【下载频次】345
节点文献中: 

本文链接的文献网络图示:

本文的引文网络